Closed Solicitation · DEPARTMENT OF HEALTH AND HUMAN SERVICES
AI Summary
The FDA's Center for Biologics Evaluation and Research seeks a service maintenance contract for the Carl Zeiss LSM900 confocal imaging system. This contract is essential to minimize downtime and ensure continued support for research programs. Interested parties should respond to this sources sought notice.
The Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER) owns a Carl Zeiss LSM900 confocal imaging system (s/n 2901000217) for fluorescence microscopy. The current maintenance contract for this system expired in 2025. The Zeiss 900 imaging system is heavily used at White Oak FDA campus as a scientific tool in CBER’s research programs to support CBER investigators.
To minimize system downtime, CBER requires a service agreement for maintenance and possible repair.
ZEISS LSM900 SERVICE MAINTENANCE CONTRACT is a federal acquisition solicitation issued by DEPARTMENT OF HEALTH AND HUMAN SERVICES. Review the full description, attachments, and submission requirements on SamSearch before the response deadline.
SamSearch Platform
AI-powered intelligence for the right opportunities, the right leads, and the right time.